ADVANTAGE: Merck Does Say “No”
- Alexander Rabin, MD
- From Harvard Vanguard Medical Associates, Mount Auburn Hospital, Cambridge, MA 02138.
TO THE EDITOR:
In their article on the ADVANTAGE seeding trial, Hill and colleagues (1) seem to put the blame on Merck and participating physicians. I think, however, that it is the system that is mostly at fault. Merck is a commercial enterprise whose major goal is to make a profit by using every legal tool available. It tried to make its customers …
RSS Feeds









